Dr Haslab - India's first homeopathic healthcare mobile application launched in India
Dr Haslab - India's first homeopathic healthcare mobile application launched in India

Haslab launches India's first homeopathy healthcare mobile application in collaboration with 3EA

ANI | Updated: Dec 17, 2020 14:03 IST


Mumbai (Maharashtra) [India], December 17 (ANI/NewsVoir): With the pandemic on all of our minds, more and more attention has been placed on personal healthcare.
To meet people's increasing needs for reliable services, the healthcare industry has been looking for innovative ways to use their resources more effectively. Recently, Hahnemann Scientific Laboratory (India) Pvt. Ltd., popularly known as Haslab, leading homeopathy brand in India, launched its health and wellness mobile application - Dr Haslab hoping to better serve patients as we all head into a new, digital, and sometimes socially-distanced future.
Haslab, is a GMP certified company and was established in 1962 by Dr KB Rastogi with an aim of promoting homeopathy among masses and providing benefits of this proven science to the mankind.
In its continuous perseverance to serve mankind, Haslab has also been recognized by Economic Times as an Iconic Brand for the year 2019-20 along with other successful brands of Indian origin.
With its current patient base in millions, Haslab in collaboration with 3EA, a management consulting group, felt the need for patient engagement outside of a traditional care setting during COVID-19. Before the pandemic, India's public healthcare system was already feeling the pressure due to factors that include an aging and growing population.
With COVID-19, everyone was quick to understand that one bad wave could send the healthcare system into overdrive. The mobile application, thus, comes amid an expansion of digital health technologies and increasing efforts by medical practitioners to extend patient experience and loyalty beyond the traditional brick-and-mortar store.
On the occasion of the release, Amit Rastogi, Director - Haslab took the opportunity to present the benefits of technology and innovation.
"Online medical appointments and check-ups via smartphone are only just the beginning for health technology in India, with the industry set to be worth more than USD 91.9 billion by 2026. COVID-19 has firmly established the need for digital health infrastructure and practice of this can prevent transmission of infectious diseases reducing the risk to both doctors and patients by avoiding social contact. The mobile application is based on the concept of 'Health Care by Homeopathy' and ensure that people 'Live Life without side effects," said Amit Rastogi.

As per the research conducted by 3EA, there has been a significant increase in health awareness and fitness among the masses in the post-COVID-19 world as compared to pre-COVID-19 world. Haslab with its tagline "Live Life Without Side Effects" is uniquely positioned to serve the masses with personalized healthcare content and telemedicine support. Homeopathy has been repeatedly used during different epidemics to improve immunity.
In fact, the phrase, 'genus epidemicus' was coined by the founder of homoeopathy, Dr Samuel Hahnemann, to indicate the remedy which could serve as a prophylactic during epidemics. Dr Hahnemann treated and advised prophylaxis during a scarlet fever epidemic and those treated with homoeopathy were known to have had significantly increased chances of survival at that time.
With its experienced team of highly qualified doctors and homeopathic assortment of over hundred medicines like Eye drops, Syrups, Homoeopathic Complex tablets, Mother tinctures, dilutions, ointments, gels and Biochemic combinations from 1 - 48, Haslab, is leveraging technology to spread awareness and making homoeopathy a preferred choice for all healthcare needs because of its gentle care and safety standards.
"Each and every homoeopathy drug has its own range of action and application. So, it is always wise and a lot safer to consult a homoeopathy doctor for the same," said Amit Rastogi.
With people avoiding visiting market places and preferring to stay indoors due to COVID-19, the online or e-commerce market for healthcare, especially supplies and medicines, is seeing a significant growth. Dr Haslab mobile application will cater to the ever-increasing demand of homeopathy medicine with easy-to-use interface and doorstep delivery and will make the communication between doctors and patients better and more convenient during COVID-19 times.
"The launch of the new app is part of our long-term plan, but the pandemic gave us the opportunity to accelerate the development process and drive our teams to explore new services that directly meet the evolving needs of our patients. Convenience is one of the factors that prompts patients to use this service. However, it can also address the public's need for safer yet more efficient services, as they would rather avoid visiting healthcare facilities during this time or may have certain symptoms that would make video consultation services preferable to coming in for an appointment," said Amit Rastogi.
Aimed at making healthcare access easier and safer without compromising on quality, efficiency or reliability of services, Dr. Haslab offers a wide range of healthcare services, including e-booking for general practitioner consultations and getting all homeopathic medicines at a single place. Through this application, Haslab wishes to fill the gap in the last-mile healthcare services.
This mobile application, conceptualized by 3EA, has been specially developed to ensure that it becomes a one-stop solution for all the healthcare needs and provide convenient online shopping experience to the patients. Haslab, with better manufacturing and distribution systems in place and newly launched app is set to embark on a mission to create a benchmark for homeopathy industry and creating sustainable healthcare and wellness solutions for One and All.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Loading...
iocl
iocl